CPHI Istanbul hosts government and industry to strengthen Turkey’s role as MENA’s pharma hub
300 content sessions stimulating new ideas to propel Turkey towards a top-ten pharma economy.
CPHI Istanbul 2016, (#cphiistanbul) organised by UBM EMEA, returns for the third consecutive year to Turkey, co-located with InnoPack, ICSE and P-MEC. The four-in-one event will take place at the Istanbul Congress Center (ICC), Turkey, from the 1 to 3 June 2016, and is heavily supported by the Ministry of Health (Turkish Medicines and Medical Devices Agency) and the Pharmaceutical Manufacturers Association of Turkey (IEIS) — highlighting the integral role it is playing in stimulating regional growth. In total, the event is forecasted to attract more than 4,200 attendees and in excess of 200 exhibitors, both domestic and international, with attendance from regional heavyweights such as DEVA, Nobel Ilac, and Pharmactive.
Turkey is already established as the regional pharmaceutical hub, and with the fastest growth rate in the OECD — averaging 6.7% per year from 2011-2018 — it is working towards the Government’s target of becoming a top ten global healthcare economy by 2023. Key to this transformation is CPHI Istanbul, which will run a high level conference in parallel to the exhibition — specifically designed to provide vital market information, key growth opportunities, and create new strategic alliances to ensure future business success.
The Turkish pharma market has an end-user spend of US$9.1 billion and is already the seventh largest in Europe, with around 80 production facilities, 20,000 employees and direct access to the pharma markets of the Middle East and North Africa. As a result, CPHI Istanbul has seen rapid growth and has cemented its role as the key event for pharmaceutical solution suppliers from across Turkey, the Balkans, the Middle East and North Africa, and South East Europe.
In the last few years, there has been a surge of industrialisation within Turkey, as the population gentrifies, and as a result, demand for higher quality pharmaceutical products is increasing. In fact, the Turkish Ministry of Science, Industry, and Technology (AIFD)’s Strategy Report, confidently predicts that the country is set to become the regional production base for medium- and high-level technology products.
Another factor contributing to rising international interest is that the Turkish pharma market still relies heavily on imports, representing 50% of the total industry output. However, a critical consideration for international suppliers looking at market entry is access to robust business intelligence to inform better decisions.
CPHI Istanbul will feature a free-to-attend conference, focused on key legislative and regulatory updates, providing sound advisory intelligence and independent practical insights for pharma manufacturers, and domestic/international buyers and suppliers. The programme is built around six core areas: 'Policy & Regulation', 'Business & Investment', 'Manufacturing', 'R&D, Innovation & New Technologies', 'Supply Chain' and 'Foreign Markets'.
The conference bridges both East and West perspectives, and key sessions include: ‘Positioning Turkey as a Regional Pharmaceutical Hub’; ‘Creating an R&D Centre Based on Entrepreneurship & Innovation: The Case for Turkey as a Pharmerging Country’; ‘Generating Value through Innovation: What the Turkish Pharma Industry Has to Offer within MENA Context?’; and ‘The Case for Turkey: Transition from Import to Local Production in Pharmaceuticals and Subsequent Need for Harmonising Supply Chain Structures’.
Orhan Caglayan, Group Director at UBM Turkey, commented: “This event has already been a huge success in the last 3 years and continues to showcase both the international and domestic appetite for pharmaceutical business. With many international attendees, and the support of regional industry and government, this event is now integral to the progressive advancement of manufacturing. It’s a diverse and evolving market, so to maximise the opportunities available, CPHI also provides a huge content platform to help both attendees and exhibitors make better-informed decisions and see the full scope of potential in this high-growth region.”
Other highlights at CPHI Istanbul 2016 include
“At our booth we had the opportunity to meet most of our business partners and distributors. Our beautiful city Istanbul attracted many international visitors to join CPHI, which provided business development opportunities between companies from different continents,” Ms. Sibel Nitelik Ödemiş — API Sales Executive & South America Region Account Manager, MN Pharmaceuticals.
Related News
-
News Pharmapack Awards 2024 Patient-Centric Design Award Winner – Dr Ferrer BioPharma
The 2024 Pharmapack Awards celebrated the best in innovation and design for the pharmaceutical packaging and drug delivery industry on January 24, 2024. -
News Women in Pharma: Minding the Gap at Pharmapack 2024
2024 marks the first year Pharmapack will host a Diversity track dedicated to bridging the gap within the pharmaceutical packaging and drug delivery sector. The track includes a panel discussion on 'Enabling Diversity in the Workplace,' focused... -
News Pharmapack Awards 2024 - Celebrating Packaging and Drug Delivery Innovation
The 2024 Pharmapack Innovation Awards ceremony celebrated the best in pharmaceutical packaging and drug delivery innovation at all levels. The awards were held on January 24, 2024 at the Paris Expo Porte de Versailles. -
News Pharmapack 2024 - From the Floor
Paris once again welcomes Europe’s leading trade show in pharmaceutical packaging and drug delivery innovation. Join our content team as Pharmapack 2024 opens its doors to leading experts and innovators in pharmaceutical packaging and drug delive... -
News CPHI Barcelona 2023: Partnering for Success – Managing Outsourcing Relationships to Optimise Manufacturing Operations
During CPHI Barcelona 2023, insightful content sessions offered attendees the chance to explore trending topics with expert speakers and panellists. Here, we summarise what the pharma industry and supply chain are talking about the most. -
News CPHI Barcelona 2023: Loading Potential – Artificial Intelligence for Pharma Manufacturing
During CPHI Barcelona 2023, insightful content sessions offered attendees the chance to explore trending topics with expert speakers and panellists. Here, we summarise what the pharma industry and supply chain are talking about the most. -
News Pharmaceutical industry supports COP28 health stance in joint statement
As COP28 takes place over this week in Dubai, UAE, several bodies in the pharmaceutical and health industries have come together to announce support of key movements in sustainability in the sector, and to recognise sustainability as a health issue.&nb... -
News CPHI Podcast Series: Start-ups take centre stage at CPHI Barcelona
The first episode of the CPHI Podcast Series since we attended CPHI Barcelona in October covers the Start-up market at the event, with expert Matthew Wise joining Editor Lucy Chard to discuss the event.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance